Asthma+me

Veröffentlicht von: Activ8rlives

Beschreibung

Asthma+me App is a Class 1 medical device Self-Care solution for children and young people aged 5-18 years old with asthma, in which parents and family members can support and monitor the wellbeing of all the children and young people under their care. This is a family-focused service, developed in collaboration with a leading NHS Paediatric Hospital in the UK.
Use of Asthma+me requires a subscription, which is handled by the App Store and will auto renew unless cancelled. You will be charged 24 hours before your renewal date. If you do not cancel 24 hours before your renewal you may be charged. If you purchase a subscription during your free trial period then any unused portion of your free trial will be forfeited. You can manage your subscription and auto-renewal settings through your iTunes Account Settings. Terms of sale can be found here: https://www.activ8rlives.com/support/
Asthma+me includes:
1. Clinician-approved Education syllabus on Asthma management: 56 simple lessons and quizzes delivered daily, provides training and instruction for the family.
2. Wireless connectivity to self-monitoring devices: Connect PUFFClicker inhaler trackers, Peak Flow/FEV1 monitor, BuddyBand2 Activity Tracker, Body Analyser Smart Scales to monitor key physiological signs.
3. Medication: record medication prescribed for each family member. Track doses and use of batches of the prescription (eg inhaler in the bag, at home, etc). Include non-inhaler medications such as antibiotics, steroids, antihistamines etc.
4. Charts and Reports: Generate custom charts to identify trends. Create pre-configured report as a PDF which can be printed, emailed or exported to clinical centres using Asthma+me.
5. Motivation: encourage children and young people to adhere to their Care Plan and medication routine. Asthma+me includes a rewards module for the child(ren) to work towards, earning points for every action completed each day to motivate and encourage.
6. Care Plan: Asthma+me brings together all of your child(ren)’s information in one, easy-to-read and printable or emailable Care Plan. EVERYONE with asthma should have a written care plan. Print and give to schools, friends, family, carers, GP and Hospitals to give clear instructions in the event of an asthma attack.

Medical device
The Asthma+me App is classified as a Class 1 medical device under MEDDEV 2. 4/1 Rev. 9 June 2010 as per the requirements set out in Annex IX of Directive 93/42/EEC as amended 2007/47/EC.
Intended Use:
Asthma+me is a mobile application intended for use in the home to assist people to receive and review information from connected medical and non-medical devices, track medication use and record other events such as asthma attacks, for effective health self-management. The user also can share the data via sharing functions.
Health and Safety Notices:
Asthma+me App is not intended to monitor vital physiological parameters where variation could result in immediate danger.
Asthma can be a life-threatening condition. Always take the medication as prescribed. If you experience any asthma-related symptoms of shortness of breath that does not get better after using your Reliever inhaler; trouble walking and talking because of shortness of breath; blue lips or fingernails; severe wheezing; or a peak flow reading of less than 50% of your personal best, refer to your Care Plan and follow the instructions carefully. If you continue to have symptoms, consult your medical team.
Do not rely on the Asthma+me App to diagnose or treat your Asthma.
Only recommended for children 5 years of age and over and only under adult supervision.
Do not rely solely on the Reminder capabilities of the Asthma+me App to take your prescribed medication as directed by your medical team.
If you experience any serious incident that occurs in relation to the Asthma+me App, please report this to Aseptika Limited (Activ8rlives) and the competent authority of the Member State in which you are based.
Ausblenden Mehr anzeigen...

In-App-Käufe

Asthma+me 1 Year Subscription
729.00 č
Asthma+me 1 Month Subscription
589.00 č
Asthma+me 3 Month Subscription
289.00 č

Screenshots

Asthma+me Häufige Fragen

  • Ist Asthma+me kostenlos?

    Ja, Asthma+me ist kostenlos herunterzuladen, enthält jedoch In-App-Käufe oder Abonnements.

  • Ist Asthma+me seriös?

    Nicht genügend Bewertungen, um eine zuverlässige Einschätzung vorzunehmen. Die App benötigt mehr Nutzerfeedback.

    Danke für die Stimme

  • Wie viel kostet Asthma+me?

    Asthma+me bietet mehrere In-App-Käufe/Abonnements, der durchschnittliche In-App-Preis beträgt 535.67 č.

  • Wie hoch ist der Umsatz von Asthma+me?

    Um geschätzte Einnahmen der Asthma+me-App und weitere AppStore-Einblicke zu erhalten, können Sie sich bei der AppTail Mobile Analytics Platform anmelden.

Benutzerbewertung
Die App ist in Tschechien noch nicht bewertet.
Bewertungsverlauf

Asthma+me Bewertungen

Keine Bewertungen in Tschechien
Die App hat noch keine Bewertungen in Tschechien.

Store-Rankings

Ranking-Verlauf
App-Ranking-Verlauf noch nicht verfügbar
Kategorien-Rankings
App ist noch nicht gerankt

Asthma+me Konkurrenten

Name
Propeller
Take Control of Asthma or COPD
NHSWales Asthmahub for Parents
Manage your child's Asthma
NHS Wales Asthmahub
Manage your Asthma
FindAir – Asthma Diary
my mhealth
COPD Asthma Diabetes Heart
Smart ANP
Track Asthma and Rhinitis
Smart Asthma: Forecast Asthma
Forecast Asthma with Peak Flow
Track My Asthma
Personal Asthma Tracker
OMRON Asthma Diary
Easy Record and Useful Review
Smart Rescue Inhaler Manager

Asthma+me Installationen

Letzte 30 Tage

Asthma+me Umsatz

Letzte 30 Tage

Asthma+me Einnahmen und Downloads

Gewinnen Sie wertvolle Einblicke in die Leistung von Asthma+me mit unserer Analytik.
Melden Sie sich jetzt an, um Zugriff auf Downloads, Einnahmen und mehr zu erhalten.

App-Informationen

Herausgeber
Activ8rlives
Sprachen
English, Polish
Letzte Veröffentlichung
3.2.2 (vor 8 Monaten )
Veröffentlicht am
Aug 30, 2019 (vor 5 Jahren )
Zuletzt aktualisiert
vor 3 Tagen
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.